127 related articles for article (PubMed ID: 4595318)
1. Introduction: animal models of immunotherapy of cancer.
Rapp HJ
Natl Cancer Inst Monogr; 1973 Dec; 39():1-2. PubMed ID: 4595318
[No Abstract] [Full Text] [Related]
2. An experimental model for immunotherapy of cancer.
Zbar B; Ribi E; Rapp HJ
Natl Cancer Inst Monogr; 1973 Dec; 39():3-9. PubMed ID: 4595326
[No Abstract] [Full Text] [Related]
3. Activated macrophages and the antitumor action of BCG.
Alexander P
Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
[No Abstract] [Full Text] [Related]
4. Immunotherapy of guinea pig cancer with BCG.
Zbar B
Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
[No Abstract] [Full Text] [Related]
5. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
Mathé G; Halle-Pannenko O; Bourut C
Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
[No Abstract] [Full Text] [Related]
6. Experimental studies of tumor immunotherapy. II. Tumor immunotherapy following tumor extirpation.
Hayashi S
Acta Med Okayama; 1976 Jun; 30(3):197-208. PubMed ID: 136871
[TBL] [Abstract][Full Text] [Related]
7. Experimental and clinical trials with BCG immunotherapy.
Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
[No Abstract] [Full Text] [Related]
8. Bacillus Calmette-Guerin in the treatment of neoplastic disease.
Laucius JF; Bodurtha AJ; Mastrangelo MJ; Creech RH
J Reticuloendothel Soc; 1974 Dec; 16(6):347-73. PubMed ID: 4616079
[No Abstract] [Full Text] [Related]
9. Active non-specific immunotherapy of experimental tumours.
Silobrcić V
Folia Biol (Praha); 1980; 26(3):145-66. PubMed ID: 6998756
[No Abstract] [Full Text] [Related]
10. Immunotherapy of guinea pig cancer with BCG.
Zbar B; Rapp HJ
Cancer; 1974 Oct; 34(4 Suppl):suppl:1532-40. PubMed ID: 4371315
[No Abstract] [Full Text] [Related]
11. [BCG vaccine in cancer immunotherapy].
Azuma I; Saiki I
Rinsho Ketsueki; 1980 Sep; 21(9):1333-5. PubMed ID: 7452921
[No Abstract] [Full Text] [Related]
12. Bacillus Calmette-Guérin and antilymphocyte serum in carcinogenesis. Effects on the hamster pouch.
Giunta JL; Reif AE; Shklar G
Arch Pathol; 1974 Oct; 98(4):237-40. PubMed ID: 4606260
[No Abstract] [Full Text] [Related]
13. [Immunotherapy of lung cancer using BCG cell-wall skeleton].
Yasumoto K
Kekkaku; 1977 Oct; 52(10):530-1. PubMed ID: 340747
[No Abstract] [Full Text] [Related]
14. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
[No Abstract] [Full Text] [Related]
15. Immunotherapy of cancer: theory and practice.
Rapp HJ
Proc Inst Med Chic; 1975; 30(8):251-5, 274. PubMed ID: 1103122
[No Abstract] [Full Text] [Related]
16. Mycobacterial cell wall components in tumor suppression and regression.
Ribi EE; Meyer TJ; Azuma I; Zbar B
Natl Cancer Inst Monogr; 1973 Dec; 39():115-9. PubMed ID: 4595311
[No Abstract] [Full Text] [Related]
17. Role of animal models in understanding intravesical therapy with bacille Calmette-Guérin.
Ratliff TL
Clin Infect Dis; 2000 Sep; 31 Suppl 3():S106-8. PubMed ID: 11010834
[TBL] [Abstract][Full Text] [Related]
18. [Immunologic capacity of cancer patients and BCG-CSW immunotherapy].
Yasumoto K; Manabe H; Yanagawa E; Nagano S; Ueda H
Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr; 27(4):449-51. PubMed ID: 381535
[No Abstract] [Full Text] [Related]
19. Immunotherapy of melanoma with intralesional BCG.
Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
[No Abstract] [Full Text] [Related]
20. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].
Ogura T
Kekkaku; 1980 Aug; 55(8):359-63. PubMed ID: 6999203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
